Literature DB >> 8088092

Clinical evaluation of exertional dyspnea.

D A Mahler1, M B Horowitz.   

Abstract

The medical history is the first step in the clinical evaluation of exertional dyspnea. It should include pertinent questions about the characteristics of dyspnea, especially descriptive qualities, onset, frequency, severity, and activities that provoke the symptom. Based on this information, along with the physical examination, the health care provider should be able to categorize the cause of exertional dyspnea as suspected cardiac disease, suspected respiratory disease, or as unexplained. Laboratory testing is ordered using a logical approach to diagnose the most probable cause of dyspnea. Cardiopulmonary exercise testing is indicated to differentiate cardiac and respiratory limitation, to document deconditioning, and to identify psychogenic dyspnea. The measurement of dyspnea and leg discomfort during exercise testing can be performed using the Borg 0 to 10 category-ratio scale or the visual analog scale. These perceptual responses can provide useful information about symptom limitation, which is complementary to physiologic data.

Entities:  

Mesh:

Year:  1994        PMID: 8088092

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  11 in total

1.  Environmental asbestos disease: pleural plaque volume measurement with Chest Tomography is there a correlation between pulmonary function?

Authors:  Ibrahim Güven Çoşğun; Fatma Evyapan; Nevzat Karabulut
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

2.  Telehealth Pulmonary Rehabilitation for Patients With Severe Chronic Obstructive Pulmonary Disease.

Authors:  Mon S Bryant; Venkata D Bandi; Christina K Nguyen; Charlie Lan; Helene K Henson; Amir Sharafkhaneh
Journal:  Fed Pract       Date:  2019-09

3.  An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility.

Authors:  Chiara M Antonioli; Giovanni Bua; Anna Frigè; Katia Prandini; Sara Radici; Mirko Scarsi; Elisabetta Danieli; Andrea Malvicini; Paolo Airo
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

4.  Exertional dyspnoea in patients with airway obstruction, with and without CO2 retention.

Authors:  S G Cloosterman; I D Hofland; C P van Schayck; H T Folgering
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

Review 5.  Breathlessness in hospitalised adult patients.

Authors:  A B Rao; D Gray
Journal:  Postgrad Med J       Date:  2003-12       Impact factor: 2.401

6.  The Impact of Twice-Daily Indacaterol/Glycopyrrolate on the Components of Health-Related Quality of Life and Dyspnea in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease.

Authors:  Donald A Mahler; Edward Kerwin; Lindsey Murray; Carole Dembek
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

Review 7.  Cardiopulmonary exercise testing: relevant but underused.

Authors:  Daniel E Forman; Jonathan Myers; Carl J Lavie; Marco Guazzi; Bartolome Celli; Ross Arena
Journal:  Postgrad Med       Date:  2010-11       Impact factor: 4.379

8.  Electromyography-Guided Botulinum Toxin Injection Into the Cricothyroid Muscles in Bilateral Vocal Fold Abductor Paralysis.

Authors:  Mustafa Sahin; Ibrahim Aydogdu; Serdar Akyildiz; Munevver Erdinc; Kerem Ozturk; Fatih Ogut
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-02       Impact factor: 3.372

9.  Proposing a standardized method for evaluating patient report of the intensity of dyspnea during exercise testing in COPD.

Authors:  Asha Hareendran; Nancy K Leidy; Brigitta U Monz; Randall Winnette; Karin Becker; Donald A Mahler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-05-28

Review 10.  Exercise dyspnea in patients with COPD.

Authors:  Loredana Stendardi; Barbara Binazzi; Giorgio Scano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.